ampicillin has been researched along with Critical Illness in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karimzadeh, I; Masjedi, M; Mirjalili, M; Mirzaei, E; Sabetian, G; Vazin, A; Zand, F | 1 |
| Baehner, T; Passon, SG; Schmidt, AR; Velten, M; Wittmann, M | 1 |
| Drummond, W; Elbarbry, F; Footer, BW; Kim, S; Stucky, NL | 1 |
| Adnan, S; Lipman, J; Paterson, DL; Roberts, JA | 1 |
| Broll, M; Burhenne, H; Burkhardt, O; Clajus, C; Hafer, C; Kaever, V; Kielstein, JT; Knitsch, W; Lorenzen, JM | 1 |
| Acquarolo, A; Candiani, A; Giannotti, C; Latronico, N; Perone, G; Urli, T | 1 |
1 review(s) available for ampicillin and Critical Illness
| Article | Year |
|---|---|
Ampicillin/sulbactam: its potential use in treating infections in critically ill patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Sulbactam | 2013 |
2 trial(s) available for ampicillin and Critical Illness
| Article | Year |
|---|---|
The clinical and paraclinical effectiveness of four-hour infusion vs. half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: An assessor-blinded randomized clinical trial.
Topics: Ampicillin; Anti-Bacterial Agents; Critical Illness; Humans; Intensive Care Units; Prospective Studies; Sepsis; Shock, Septic; Sulbactam | 2023 |
Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study.
Topics: Adult; Ampicillin; Antibiotic Prophylaxis; Brain Injuries; Cohort Studies; Coma; Critical Illness; Drug Resistance; Female; Humans; Italy; Male; Middle Aged; Pneumonia; Prospective Studies; Respiration, Artificial; Sulbactam | 2005 |
3 other study(ies) available for ampicillin and Critical Illness
| Article | Year |
|---|---|
Evaluation of continuous ampicillin/sulbactam infusion in critically ill patients.
Topics: Ampicillin; Anti-Bacterial Agents; Critical Illness; Humans; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam | 2023 |
Pharmacokinetics of ampicillin during venovenous extracorporeal membrane oxygenation: A case report.
Topics: Ampicillin; Anti-Bacterial Agents; Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Sepsis | 2023 |
Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Anuria; Area Under Curve; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Equipment Design; Female; Germany; Half-Life; Humans; Infusions, Intravenous; Male; Membranes, Artificial; Metabolic Clearance Rate; Middle Aged; Models, Biological; Polymers; Prospective Studies; Renal Dialysis; Sulbactam; Sulfones; Young Adult | 2012 |